Artillegence Bio-Innovations Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Share holding
• Capital structures
• Ratio

Mar ' 12	Mar ' 11	Mar ' 10	Mar ' 09	Mar ' 08

Sources of funds

Owner's fund

Equity share capital

7.32

7.32

7.32

7.32

7.32

Share application money

-

-

-

-

-

Preference share capital

-

-

-

-

-

Reserves & surplus

19.03

19.02

19.31

19.30

19.29

Loan funds

Secured loans

-

-

-

-

-

Unsecured loans

-

-

-

-

-

Total

26.35

26.35

26.63

26.63

26.62

Uses of funds

Fixed assets

Gross block

-

-

-

-

-

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

-

-

-

-

-

Net block

-

-

-

-

-

Capital work-in-progress

-

-

-

-

-

Investments

5.76

8.37

6.64

17.59

1.16

Net current assets

Current assets, loans & advances

20.59

18.67

39.98

21.59

30.16

Less : current liabilities & provisions

-

0.69

19.99

12.56

4.70

Total net current assets

20.59

17.98

19.99

9.03

25.46

Miscellaneous expenses not written

-

-

-

-

-

Total

26.35

26.35

26.63

26.63

26.62

Notes:

Book value of unquoted investments

5.76

8.37

6.64

17.59

1.16

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

-

-

-

-

Number of equity sharesoutstanding (Lacs)

73.23

73.23

73.23

73.23

73.23